First Manhattan’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-55,800
Closed -$441K 1622
2022
Q2
$441K Buy
+55,800
New +$441K ﹤0.01% 564
2018
Q3
Sell
-128,244
Closed -$861K 1434
2018
Q2
$861K Sell
128,244
-16,200
-11% -$109K 0.01% 470
2018
Q1
$1.24M Sell
144,444
-271,920
-65% -$2.33M 0.01% 406
2017
Q4
$8.66M Buy
416,364
+399,764
+2,408% +$8.31M 0.05% 207
2017
Q3
$293K Buy
+16,600
New +$293K ﹤0.01% 610